PMID- 22859314 OWN - NLM STAT- MEDLINE DCOM- 20130327 LR - 20161125 IS - 1096-0929 (Electronic) IS - 1096-0929 (Linking) VI - 130 IP - 1 DP - 2012 Nov TI - New approaches to assess the transthyretin binding capacity of bioactivated thyroid hormone disruptors. PG - 94-105 LID - 10.1093/toxsci/kfs228 [doi] AB - Polychlorinated biphenyls (PCBs) and polybrominated diphenyl-ethers (PBDEs) are metabolized into hydroxylated metabolites (OH-PCBs/PBDEs), which can disrupt the thyroid hormone homeostasis. Binding of these metabolites to transport proteins such as transthyretin (TTR) is an important mechanism of their toxicity. Several methods to quantify the competitive thyroxine (T(4)) displacement potency of pure metabolites exist. However, quantification of the potency of in vitro metabolized PCBs and PBDEs has drawbacks related to the coextraction of compounds disturbing the T(4)-TTR competitive binding assay. This study identifies and quantifies the major coextractants namely cholesterol, saturated and nonsaturated fatty acids (SFA and NSFA) at levels above 20 nmol per mg equivalent protein following various extraction methods. Their TTR binding potency was analyzed in a downscaled, nonradioactive fluorescence displacement assay. At concentration factors needed for TTR competitive binding, at least 10muM of these coextracts is present, whereas individual SFA and NSFA disturb the assay from 0.3muM. The effectiveness of the in vitro metabolism and extraction of the model compounds CB 77 and BDE 47 was chemically quantified with a newly developed chromatographic method analyzing silylated derivatives of the OH-metabolites and coextractants. A new method to selectively extract metabolites and limit coextraction of disturbing compounds to less than 5 nmol per mg equivalent protein is presented. It is now possible to make a dose-response curve up to 50% inhibition with bioactivated CB 77 and BDE 47. The toxic potencies of bioactivated persistent organic pollutants (POPs) should be taken into account to prevent serious underestimation of their hazard and risk. FAU - Montano, Mauricio AU - Montano M AD - Centre de Recherche Public - Gabriel Lippmann, Department Environment and Agro-biotechnologies, L-4422 Belvaux, Grand Duchy of Luxembourg. FAU - Cocco, Emmanuelle AU - Cocco E FAU - Guignard, Cedric AU - Guignard C FAU - Marsh, Goran AU - Marsh G FAU - Hoffmann, Lucien AU - Hoffmann L FAU - Bergman, Ake AU - Bergman A FAU - Gutleb, Arno Christian AU - Gutleb AC FAU - Murk, Albertinka Jacoba AU - Murk AJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120801 PL - United States TA - Toxicol Sci JT - Toxicological sciences : an official journal of the Society of Toxicology JID - 9805461 RN - 0 (Endocrine Disruptors) RN - 0 (Environmental Pollutants) RN - 0 (Fatty Acids) RN - 0 (Fatty Acids, Unsaturated) RN - 0 (Halogenated Diphenyl Ethers) RN - 0 (Polybrominated Biphenyls) RN - 0 (Prealbumin) RN - 0N97R5X10X (2,2',4,4'-tetrabromodiphenyl ether) RN - 97C5T2UQ7J (Cholesterol) RN - DFC2HB4I0K (Polychlorinated Biphenyls) RN - Q51BO43MG4 (Thyroxine) RN - Y2I6546TMI (3,4,3',4'-tetrachlorobiphenyl) SB - IM MH - Animals MH - Cholesterol/chemistry/metabolism MH - Chromatography, High Pressure Liquid MH - Endocrine Disruptors/*metabolism MH - Environmental Pollutants/chemistry/*metabolism MH - Fatty Acids/chemistry/metabolism MH - Fatty Acids, Unsaturated/chemistry/metabolism MH - Halogenated Diphenyl Ethers MH - Microsomes, Liver/drug effects/metabolism MH - Polybrominated Biphenyls/chemistry/*metabolism MH - Polychlorinated Biphenyls/chemistry/*metabolism MH - Prealbumin/*metabolism MH - Protein Binding MH - Rats MH - Rats, Sprague-Dawley MH - Thyroxine/*metabolism EDAT- 2012/08/04 06:00 MHDA- 2013/03/28 06:00 CRDT- 2012/08/04 06:00 PHST- 2012/08/04 06:00 [entrez] PHST- 2012/08/04 06:00 [pubmed] PHST- 2013/03/28 06:00 [medline] AID - kfs228 [pii] AID - 10.1093/toxsci/kfs228 [doi] PST - ppublish SO - Toxicol Sci. 2012 Nov;130(1):94-105. doi: 10.1093/toxsci/kfs228. Epub 2012 Aug 1.